)
Working Groups
Introducing the Marathon of Hope Cancer Centres Network Working Groups
The Marathon of Hope Cancer Centres Network (MOHCCN) is uniting patients, researchers, oncologists and administrators from leading cancer centres and hospitals across Canada to collaborate on projects that will accelerate precision medicine for the benefit of cancer patients.
These collaborations are fostered through the work of the MOHCCN Working Groups. These groups have been operating ever since funding for the Network was announced by the Federal Government in March 2019, when it was determined that the Network should operate according to agreed standards and guidelines recommended by experts from across the country.
Meet our Working Groups
Currently, the MOHCCN is supported by 11 Working Groups, who come together on a regular basis to draft the guidelines, standards, and policies that govern the Network.
While each of these working groups tackles a different area of cancer research and is made up of a wide array of expertise, these groups operate in unison, maximizing the potential for impact of the Network while helping to create the Team Canada of Cancer Research.
Hematology Biospecimens Subgroup
Scientific Questions Working Group
- Connect and represent scientific communities across the spectrum of the Network
- Provide overarching scientific questions and themes as a guide to Network activities
- Recommend priorities for funding and future cohort selection
Biospecimens Working Group
Return of Results Subgroup
Technology Working Group
Immune Profiling Subgroup
IP and Commercialization Working Group
Develop MOHCCN policies as it relates to the following:
- Definition of the various relevant categories of generated intellectual property under the consortium (“Foreground IP”)
- Ownership of each category Foreground IP
- Revenue sharing (as distinct from ownership) as it relates to:
- Foreground IP arising from Academic (non-commercial/no commercial funding) Secondary Studies using MOH/Member Resources
- Foreground IP arising from Commercially Funded (Sponsored Research) Secondary Studies using MOH/Member Resources
- Foreground IP arising from Commercial Entity Directed Studies using MOH/Member Resources
- Revenue sharing (as distinct from ownership) as it relates to each of the above – where the Secondary Study is MOH Funded.
- Developing a Framework for “Rules” as it relates to third-party Sponsored Research and/or third-party Funded Research as it relates to Access to the MOH Resources to ensure reasonable/fair access and terms.
Health Technology Assessment Working Group
Clinical Data Model Guideline Subgroup
To create a comprehensive data curation guideline for the MOHCCN Clinical Data Model.
*Please note that this is a subgroup of the Clinical Data Standards Subcommittee.
Clinical Data Standards Sub-Committee
Data Policy and Standards Committee
Canadian Spectrum Working Group
To develop inclusion strategies for the under-represented population. It should reflect all of the Canadian Spectrum:
- Rare cancers
- Rural and remote
- Indigenous people
- Immigrant population
- Refugees
- Low income/high income.